Developer docs
API playgroundTry for free, no card

Search company profiles

Nucleus

Full company profile

uuid0000c7f

Namestring
Nucleus
Legal namestring
Nucleus Genomics Inc.
Websiteurl
mynucleus.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Nucleus Genomics Inc. is a New York-based consumer genetics company founded in 2021 by Kian Sadeghi that builds genetic testing products on clinical-grade whole-genome sequencing and proprietary polygenic risk score models. Its core technology sequences 1,000 times more DNA than microarray-based competitors such as 23andMe and applies a family of nine internally developed polygenic predictors — branded as Origin — to assess risk for more than 2,000 hereditary conditions and traits, including complex diseases (cancers, diabetes, heart disease, Alzheimer's), neurological conditions, and physical traits such as height, eye color, and intelligence.

The product portfolio spans Nucleus Preview and Nucleus Health (at-home cheek-swab kits with carrier screening priced in the low hundreds), Nucleus Embryo (software that analyzes up to 20 IVF embryo PGT files for prospective parents), and Nucleus IVF+ (a premium package priced at approximately $30,000 that bundles embryo analysis with fertility-clinic concierge services). An annual membership renews for ongoing model updates. Distribution combines direct-to-consumer e-commerce through mynucleus.com with a clinic-anchored IVF+ Network of more than 165 partner fertility clinics across nearly all U.S. states, India, the Middle East, and Mexico. U.S. tests are physician-ordered and reviewed through an independent physician network, with HIPAA-compliant handling and CLIA-certified lab processing.

The company is privately held and venture-backed, having raised approximately $31.5 million across a 2021 seed, a 2022 Seed+ led by Seven Seven Six, and a January 2025 Series A. In 2025 it acquired Cambrean, an Irish AI-wearable health platform, and received a strategic investment from Samsung Next to reposition toward a broader preventive health genomics platform that combines genetic baselines with continuous biometric data. The leadership team includes Founder/CEO Kian Sadeghi, CTO Varun Jana, CSO Arash Keshavarzi Arshadi, Chief Clinical Officer Nathan Treff, and COO Caio Hachem.

Short descriptiontext

Nucleus Genomics is a consumer genetics company that uses whole-genome sequencing and proprietary polygenic risk score models to sell at-home genetic tests, IVF embryo analysis software, and a $30,000 IVF concierge package to couples, IVF patients, and partner fertility clinics worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
whole-genome sequencing, polygenic risk scoring, consumer genetic testing, embryo genetic analysis, carrier screening
Industry4 codes
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Consumer Genomics and Genetic Testing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Nucleus Preview (Direct-to-Consumer DNA Testing)
TypeOne Time License
Description

At-home cheek-swab kits for whole-genome sequencing with carrier screening. Sold directly to consumers through the website. Price point in the low-hundreds of dollars for the at-home test kit.

mynucleus.com
2Nucleus Embryo
TypeOne Time License
Description

Software-based embryo analysis service allowing comparison of embryos across health and trait categories. Includes analysis for up to 20 embryo PGT files, two carrier screening DNA kits, and one genetic counseling session. Automatic updates to embryo analysis results as models improve.

mynucleus.com
3Nucleus IVF+
TypeOne Time License
Description

Comprehensive package combining Nucleus Embryo with IVF concierge services including facilitation with fertility clinics. Priced at approximately $30,000.

mynucleus.com
4Membership/Subscription
TypeSubscription Recurring
Description

Annual membership renewal for ongoing access to results, automatic updates, and features. Membership renews annually on its anniversary date.

ndtv.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Others
Pricing details4 tiers
1Nucleus Preview - At-home genetic testing for couples or individuals
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

At-home cheek-swab kit (single or partner kit depending on package) with whole-genome sequencing, carrier screening, and digital reports. Price in low-hundreds of dollars.

mynucleus.com
2Nucleus Embryo - Embryo genetic analysis software
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Embryo analysis for up to 20 PGT files, hereditary disorder analysis, two carrier screening DNA kits for parents, one genetic counseling session, automatic result updates. 14-day refund window.

mynucleus.com
3Nucleus IVF+ - Comprehensive IVF embryo selection package
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$30,000 IVF+ package including embryo ranking for predicted intelligence and disease risk, clinic concierge services. Advertised via subway advertisements in November 2025.

shanakaanslemperera.substack.com
4Annual Membership
ModelSubscriptionBilling cadenceAnnual
Notes

Annual membership renewal for ongoing access, automatic model updates, and membership features. Cancel within 7 days of term start for full refund.

mynucleus.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1Nucleus Health
Description

At-home cheek-swab kit for whole-genome sequencing with carrier screening

mynucleus.com
+4 more records
Core offering1 text field

Nucleus provides direct-to-consumer genetic testing built on clinical-grade whole-genome sequencing, including at-home cheek-swab kits (Preview, Health) with carrier screening and polygenic risk scoring, as well as Nucleus Embryo and Nucleus IVF+ packages that compare IVF embryos across hereditary disease risks and traits for prospective parents. The company also operates Nucleus Labs, which develops the Origin family of polygenic prediction models and the Genetic Optimization Hub for research transparency.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Screens for over 2,000 genetic conditions and traits per embryo
+3 more records
Product overview1 text field

Nucleus offers a suite of consumer genomic health products centered on whole-genome sequencing and polygenic risk scoring. The core portfolio consists of Nucleus Preview and Nucleus Health (at-home genetic testing kits with carrier screening), Nucleus Embryo (IVF embryo analysis software), and Nucleus IVF+ (premium IVF concierge service). Supporting the product line, Nucleus Labs developed Origin, a family of nine AI-powered polygenic prediction models, and the Genetic Optimization Hub for research transparency. All services process genetic data through CLIA-certified laboratories and deliver results via digital reports accessible through the Nucleus platform.

Product and service6 records
1Nucleus Preview
CategoryAt-home genetic testing
Description

At-home cheek-swab kit for couples (or individuals) that performs clinical-grade whole-genome sequencing with carrier screening, allowing partners to sync results and assess hereditary disease risks before conception. Priced in the low hundreds of dollars.

2Nucleus Health
CategoryAt-home genetic testing
Description

At-home cheek-swab kit with whole-genome sequencing, comprehensive health insights and genetic risk assessments, processed by a CLIA-certified lab. In the U.S. it is physician-ordered and reviewed through an independent physician network, with digital reports delivered to the consumer.

3Nucleus Embryo
CategoryEmbryo analysis software
Description

Software-based embryo analysis service for IVF patients that compares up to 20 embryo PGT files across broad health and trait categories, screening for hereditary disorders, cancers, chronic conditions, and neurological/mental health risks. Includes two carrier screening DNA kits for biological parents and one genetic counseling session, with automatic result updates as models improve.

4Nucleus IVF+
CategoryIVF concierge service
Description

Premium full-service package combining Nucleus Embryo analysis with IVF concierge services, including facilitation with fertility clinics and embryo ranking for predicted intelligence, disease risk, and physical traits such as eye color and height. Priced at approximately $30,000 and distributed through the IVF+ network of 160+ partner clinics globally.

5Origin
CategoryAI/ML genetic models
Description

Family of nine advanced polygenic prediction models that estimate human longevity and health outcomes from embryo DNA, described as the most predictive genetic models ever built for reproductive health applications. Available under license for non-commercial research and internal evaluation.

6Genetic Optimization Hub
CategoryResearch platform
Description

Public-facing Nucleus Labs hub where companies, labs, and researchers can open-weight and share the accuracy of their genetic optimization models, supporting transparency in polygenic score methodologies.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-09
Description

Hawaii's largest IVF institution joined the Nucleus IVF+ Network. Provides advanced genetic embryo analysis for IVF patients, expanding access for local and international patients including those from Asia, Australia, and New Zealand.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-07
Description

Pasadena fertility clinic joined Nucleus IVF+ Network. Integrated advanced genetic testing into fertility services across four California locations. Offers carrier screening and embryo analysis for 2,000+ rare inherited conditions.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-26
Description

India-based IVF clinic partnership for embryo testing technology expansion to India. Part of broader international expansion strategy targeting Asian markets.

4Abu Ghosh Fertility Group
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-26
Description

Middle East expansion partnership covering Saudi Arabia and Jordan. Enables embryo testing services in the region for disease risk prediction and trait analysis.

bloomberg.com
5Cambrean
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-31
Description

Acquisition of AI-powered wearable health platform Cambrean. Accelerates Nucleus's shift toward combining genetic baselines with continuous biometric data for personalized health insights. Part of broader preventive health genomics repositioning.

femtechinsider.com
6Bryan Johnson's Don't Die Program
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Partnership with Bryan Johnson's longevity program. Nucleus services integrated into the Don't Die lifestyle optimization platform. Positions Nucleus as part of premium longevity ecosystem.

femtechinsider.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

New York City fertility clinic partnered with Nucleus. Latest clinic to join the IVF+ network, bringing advanced genetic embryo analysis to NYC patients.

8Beverly Hills Fertility
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Premium Beverly Hills fertility clinic partnered with Nucleus for exclusive network launch. Represents high-end segment of fertility market.

mynucleus.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-authored research on base editing technology for human embryo gene editing. Committed to funding further studies on embryo editing. Positions Nucleus at the frontier of reproductive genetics research.

10HelpCureHD
Strategic tierMinorTypeOthers
Description

Nonprofit partner committed to eradicating Huntington's disease. Part of Nucleus Cares program supporting families who need advanced reproductive care for medical reasons. HelpCureHD identifies and refers families to Nucleus services.

mynucleus.com
11Genomic Prediction
Strategic tierCoreTypeTechnology or Integration
Description

Partnership (2025) for Nucleus Embryo product launch. Combined expertise in polygenic embryo screening. Note: Genomic Prediction filed lawsuit in 2025 against former employees for misappropriation of embryonic DNA sequencing technology.

femtechinsider.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large publicly-traded reproductive and oncology genetics company offering PGT-A, carrier screening, and hereditary cancer testing. Competes with Nucleus in the IVF clinic channel via established reproductive health products.

2Sema4
TypeBroad incumbent
Description

Clinical genomic testing company providing reproductive health, hereditary cancer, and rare disease diagnostics. Comparable in clinical-grade genetic testing for reproductive and consumer health contexts.

3Genomic Prediction
TypeDirect peer
Description

Pioneer in polygenic embryo screening for IVF. Both a Nucleus partner (for the Nucleus Embryo launch) and a direct competitor offering PGT-P across similar clinical use cases including disease risk and trait prediction.

TypeEmerging player
Description

Personalized health and longevity platform integrating blood biomarkers, DNA, and wearable data. Comparable to Nucleus's strategic direction toward combining genetic baselines with continuous biometric monitoring.

TypeBroad incumbent
Description

Consumer genetics platform offering ancestry and health DNA tests globally. Comparable to Nucleus's DTC at-home kit business, though with deeper international reach and broader product portfolio.

TypeDirect peer
Description

DNA testing platform offering clinical-grade sequencing for health and wellness applications. Comparable on whole-exome/whole-genome sequencing infrastructure and consumer health focus.

7Function Health
TypeEmerging player
Description

Preventive health platform offering comprehensive bloodwork and diagnostics on a membership model. Directly comparable to Nucleus's post-Cambrean preventive health pivot combining genetic and biometric data.

TypeBroad incumbent
Description

Largest consumer genetic testing brand in the U.S. Nucleus explicitly differentiates on whole-genome sequencing versus 23andMe's array-based genotyping. Both target health-conscious consumers seeking genetic insights.

TypeBroad incumbent
Description

Major fertility and reproductive health company offering PGT-A services through fertility clinics globally. Comparable as an established channel for preimplantation genetic testing in the IVF market Nucleus targets.

TypeDirect peer
Description

Direct competitor in polygenic embryo screening for IVF patients. Offers whole-genome sequencing-based embryo analysis and is positioned alongside Nucleus as a category leader in PGT-P, frequently cited together in press coverage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nucleus

Consumer Genomics and Genetic Testingmynucleus.com

Nucleus Genomics is a consumer genetics company that uses whole-genome sequencing and proprietary polygenic risk score models to sell at-home genetic tests, IVF embryo analysis software, and a $30,000 IVF concierge package to couples, IVF patients, and partner fertility clinics worldwide.

What Nucleus does

Nucleus Genomics Inc. is a New York-based consumer genetics company founded in 2021 by Kian Sadeghi that builds genetic testing products on clinical-grade whole-genome sequencing and proprietary polygenic risk score models. Its core technology sequences 1,000 times more DNA than microarray-based competitors such as 23andMe and applies a family of nine internally developed polygenic predictors — branded as Origin — to assess risk for more than 2,000 hereditary conditions and traits, including complex diseases (cancers, diabetes, heart disease, Alzheimer's), neurological conditions, and physical traits such as height, eye color, and intelligence.

The product portfolio spans Nucleus Preview and Nucleus Health (at-home cheek-swab kits with carrier screening priced in the low hundreds), Nucleus Embryo (software that analyzes up to 20 IVF embryo PGT files for prospective parents), and Nucleus IVF+ (a premium package priced at approximately $30,000 that bundles embryo analysis with fertility-clinic concierge services). An annual membership renews for ongoing model updates. Distribution combines direct-to-consumer e-commerce through mynucleus.com with a clinic-anchored IVF+ Network of more than 165 partner fertility clinics across nearly all U.S. states, India, the Middle East, and Mexico. U.S. tests are physician-ordered and reviewed through an independent physician network, with HIPAA-compliant handling and CLIA-certified lab processing.

The company is privately held and venture-backed, having raised approximately $31.5 million across a 2021 seed, a 2022 Seed+ led by Seven Seven Six, and a January 2025 Series A. In 2025 it acquired Cambrean, an Irish AI-wearable health platform, and received a strategic investment from Samsung Next to reposition toward a broader preventive health genomics platform that combines genetic baselines with continuous biometric data. The leadership team includes Founder/CEO Kian Sadeghi, CTO Varun Jana, CSO Arash Keshavarzi Arshadi, Chief Clinical Officer Nathan Treff, and COO Caio Hachem.

Nucleus firmographics

Firmographics
Name
Nucleus
Legal name
Nucleus Genomics Inc.
Website
https://mynucleus.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Nucleus Genomics is a consumer genetics company that uses whole-genome sequencing and proprietary polygenic risk score models to sell at-home genetic tests, IVF embryo analysis software, and a $30,000 IVF concierge package to couples, IVF patients, and partner fertility clinics worldwide.
Ownership category
akta.pro rank

Nucleus industry classification

Industry
Product category
Consumer Genomics and Genetic Testing
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • Whole-genome sequencing
  • Polygenic risk scoring
  • Consumer genetic testing
  • Embryo genetic analysis
  • Carrier screening

Where Nucleus is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Nucleus business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Nucleus Preview (Direct-to-Consumer DNA Testing): At-home cheek-swab kits for whole-genome sequencing with carrier screening. Sold directly to consumers through the website. Price point in the low-hundreds of dollars for the at-home test kit.
  2. Nucleus Embryo: Software-based embryo analysis service allowing comparison of embryos across health and trait categories. Includes analysis for up to 20 embryo PGT files, two carrier screening DNA kits, and one genetic counseling session. Automatic updates to embryo analysis results as models improve.
  3. Nucleus IVF+: Comprehensive package combining Nucleus Embryo with IVF concierge services including facilitation with fertility clinics. Priced at approximately $30,000.
  4. Membership/Subscription: Annual membership renewal for ongoing access to results, automatic updates, and features. Membership renews annually on its anniversary date.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goNucleus Preview - At-home genetic testing for couples or individuals
One time/ perpetual licensePay-as-you-goNucleus Embryo - Embryo genetic analysis software
One time/ perpetual licensePay-as-you-goNucleus IVF+ - Comprehensive IVF embryo selection package
SubscriptionAnnualAnnual Membership

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Nucleus product offering

Product offering

Core offering

Nucleus provides direct-to-consumer genetic testing built on clinical-grade whole-genome sequencing, including at-home cheek-swab kits (Preview, Health) with carrier screening and polygenic risk scoring, as well as Nucleus Embryo and Nucleus IVF+ packages that compare IVF embryos across hereditary disease risks and traits for prospective parents. The company also operates Nucleus Labs, which develops the Origin family of polygenic prediction models and the Genetic Optimization Hub for research transparency.

Product overview

Nucleus offers a suite of consumer genomic health products centered on whole-genome sequencing and polygenic risk scoring. The core portfolio consists of Nucleus Preview and Nucleus Health (at-home genetic testing kits with carrier screening), Nucleus Embryo (IVF embryo analysis software), and Nucleus IVF+ (premium IVF concierge service). Supporting the product line, Nucleus Labs developed Origin, a family of nine AI-powered polygenic prediction models, and the Genetic Optimization Hub for research transparency. All services process genetic data through CLIA-certified laboratories and deliver results via digital reports accessible through the Nucleus platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Nucleus Health: At-home cheek-swab kit for whole-genome sequencing with carrier screening
  • Nucleus Preview
  • Nucleus Embryo
  • Nucleus IVF+
  • Origin

Products and services

  • Nucleus Preview At-home cheek-swab kit for couples (or individuals) that performs clinical-grade whole-genome sequencing with carrier screening, allowing partners to sync results and assess hereditary disease risks before conception. Priced in the low hundreds of dollars.
  • Nucleus Health At-home cheek-swab kit with whole-genome sequencing, comprehensive health insights and genetic risk assessments, processed by a CLIA-certified lab. In the U.S. it is physician-ordered and reviewed through an independent physician network, with digital reports delivered to the consumer.
  • Nucleus Embryo Software-based embryo analysis service for IVF patients that compares up to 20 embryo PGT files across broad health and trait categories, screening for hereditary disorders, cancers, chronic conditions, and neurological/mental health risks. Includes two carrier screening DNA kits for biological parents and one genetic counseling session, with automatic result updates as models improve.
  • Nucleus IVF+ Premium full-service package combining Nucleus Embryo analysis with IVF concierge services, including facilitation with fertility clinics and embryo ranking for predicted intelligence, disease risk, and physical traits such as eye color and height. Priced at approximately $30,000 and distributed through the IVF+ network of 160+ partner clinics globally.
  • Origin Family of nine advanced polygenic prediction models that estimate human longevity and health outcomes from embryo DNA, described as the most predictive genetic models ever built for reproductive health applications. Available under license for non-commercial research and internal evaluation.
  • Genetic Optimization Hub Public-facing Nucleus Labs hub where companies, labs, and researchers can open-weight and share the accuracy of their genetic optimization models, supporting transparency in polygenic score methodologies.

Quantifiable outcome

  • Screens for over 2,000 genetic conditions and traits per embryo
  • +3 more outcomes

Companies that use Nucleus

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Nucleus technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature4 records

Nucleus partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • Fertility Institute of HawaiicoreChannel Partner/ Reseller/ Distributor · 9 June 2026Hawaii's largest IVF institution joined the Nucleus IVF+ Network. Provides advanced genetic embryo analysis for IVF patients, expanding access for local and international patients including those from Asia, Australia, and New Zealand.
  • Southern California Reproductive Center (SCRC)coreChannel Partner/ Reseller/ Distributor · 7 June 2026Pasadena fertility clinic joined Nucleus IVF+ Network. Integrated advanced genetic testing into fertility services across four California locations. Offers carrier screening and embryo analysis for 2,000+ rare inherited conditions.
  • Indira IVFcoreChannel Partner/ Reseller/ Distributor · 26 March 2026India-based IVF clinic partnership for embryo testing technology expansion to India. Part of broader international expansion strategy targeting Asian markets.
  • Abu Ghosh Fertility GroupcoreChannel Partner/ Reseller/ Distributor · 26 March 2026Middle East expansion partnership covering Saudi Arabia and Jordan. Enables embryo testing services in the region for disease risk prediction and trait analysis.
  • CambreancoreStrategic or Co-development Partner · 31 January 2025Acquisition of AI-powered wearable health platform Cambrean. Accelerates Nucleus's shift toward combining genetic baselines with continuous biometric data for personalized health insights. Part of broader preventive health genomics repositioning.
  • Bryan Johnson's Don't Die ProgramcoreStrategic or Co-development Partner · 1 January 2025Partnership with Bryan Johnson's longevity program. Nucleus services integrated into the Don't Die lifestyle optimization platform. Positions Nucleus as part of premium longevity ecosystem.
  • Neway FertilityminorChannel Partner/ Reseller/ DistributorNew York City fertility clinic partnered with Nucleus. Latest clinic to join the IVF+ network, bringing advanced genetic embryo analysis to NYC patients.
  • Beverly Hills FertilityminorChannel Partner/ Reseller/ DistributorPremium Beverly Hills fertility clinic partnered with Nucleus for exclusive network launch. Represents high-end segment of fertility market.
  • Columbia University (Dr. Dieter Egli lab)coreStrategic or Co-development PartnerCo-authored research on base editing technology for human embryo gene editing. Committed to funding further studies on embryo editing. Positions Nucleus at the frontier of reproductive genetics research.
  • HelpCureHDminorOthersNonprofit partner committed to eradicating Huntington's disease. Part of Nucleus Cares program supporting families who need advanced reproductive care for medical reasons. HelpCureHD identifies and refers families to Nucleus services.
  • Genomic PredictioncoreTechnology or IntegrationPartnership (2025) for Nucleus Embryo product launch. Combined expertise in polygenic embryo screening. Note: Genomic Prediction filed lawsuit in 2025 against former employees for misappropriation of embryonic DNA sequencing technology.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Nucleus competitors and assessment

Company assessment

Broad incumbents

  • Natera: Large publicly-traded reproductive and oncology genetics company offering PGT-A, carrier screening, and hereditary cancer testing. Competes with Nucleus in the IVF clinic channel via established reproductive health products.
  • Sema4: Clinical genomic testing company providing reproductive health, hereditary cancer, and rare disease diagnostics. Comparable in clinical-grade genetic testing for reproductive and consumer health contexts.
  • MyHeritage: Consumer genetics platform offering ancestry and health DNA tests globally. Comparable to Nucleus's DTC at-home kit business, though with deeper international reach and broader product portfolio.
  • 23andMe: Largest consumer genetic testing brand in the U.S. Nucleus explicitly differentiates on whole-genome sequencing versus 23andMe's array-based genotyping. Both target health-conscious consumers seeking genetic insights.
  • CooperSurgical (PGT): Major fertility and reproductive health company offering PGT-A services through fertility clinics globally. Comparable as an established channel for preimplantation genetic testing in the IVF market Nucleus targets.

Direct peers

  • Genomic Prediction: Pioneer in polygenic embryo screening for IVF. Both a Nucleus partner (for the Nucleus Embryo launch) and a direct competitor offering PGT-P across similar clinical use cases including disease risk and trait prediction.
  • Helix: DNA testing platform offering clinical-grade sequencing for health and wellness applications. Comparable on whole-exome/whole-genome sequencing infrastructure and consumer health focus.
  • Orchid Health: Direct competitor in polygenic embryo screening for IVF patients. Offers whole-genome sequencing-based embryo analysis and is positioned alongside Nucleus as a category leader in PGT-P, frequently cited together in press coverage.

Emerging players

  • InsideTracker: Personalized health and longevity platform integrating blood biomarkers, DNA, and wearable data. Comparable to Nucleus's strategic direction toward combining genetic baselines with continuous biometric monitoring.
  • Function Health: Preventive health platform offering comprehensive bloodwork and diagnostics on a membership model. Directly comparable to Nucleus's post-Cambrean preventive health pivot combining genetic and biometric data.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Nucleus social profiles

Digital presence

Nucleus compliance and trust

Trust signal

Compliance2 records

Nucleus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nucleus leadership team

Management profile

Number of profiles

Profiles6 records

Nucleus subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Nucleus funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nucleus M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nucleus

What does Nucleus do?

Nucleus provides direct-to-consumer genetic testing built on clinical-grade whole-genome sequencing, including at-home cheek-swab kits (Preview, Health) with carrier screening and polygenic risk scoring, as well as Nucleus Embryo and Nucleus IVF+ packages that compare IVF embryos across hereditary disease risks and traits for prospective parents. The company also operates Nucleus Labs, which develops the Origin family of polygenic prediction models and the Genetic Optimization Hub for research transparency.

Is Nucleus a public or private company?

Nucleus is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nucleus founded?

Nucleus was founded in 2021. It employs 11 to 50 people.

Where is Nucleus based?

Nucleus is headquartered in New York, United States, in the North America region.

How does Nucleus make money?

Four revenue lines are on record. Nucleus Preview (Direct-to-Consumer DNA Testing) is the primary driver. The others are nucleus Embryo, nucleus IVF+ and membership/Subscription.

Who are Nucleus's main competitors?

Broad incumbents on record are Natera, Sema4, MyHeritage, 23andMe and CooperSurgical (PGT). Direct peers are Genomic Prediction, Helix and Orchid Health. Emerging players are InsideTracker and Function Health.

Does Nucleus have an API?

Yes. Nucleus operates a public status API that provides JSON endpoints for checking system status. The API offers two GET endpoints: (1) /v3/summary.json returns overall status including page name, URL, status (UP), active incidents with impact levels, and active maintenance information; (2) /v3/components.json returns component-level status for services like the App (currently showing OPERATIONAL status). This API is read-only and serves the status page infrastructure using the Instatus service. Developer documentation is at status.mynucleus.com/en-us/public-api.

What industry is Nucleus in?

Nucleus's product category is Consumer Genomics and Genetic Testing. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The GuardianWould you pay to have the ‘best baby’? Liberal eugenics and the troubling quest for human perfectionRosemarie Garland-Thomson argues that liberal eugenics, exemplified by Nucleus Genomics' 'best baby' ads, promotes a neo-eugenic quest for human perfection. She contends that such individualist optimization ignores disability as human variation and undermines social progress. She advocates for a world that accommodates imperfection rather than striving for a 'best baby'.AdAgeNucleus Genomics’ ‘Have Your Best Baby’ ads are back, now with IVF doctors - Ad AgeNucleus Genomics is expanding its 'Have Your Best Baby' campaign nationwide, featuring more than a dozen physicians in outdoor ads across five cities. The campaign, developed in-house, extends last year's provocative NYC campaign by making fertility doctors the public faces of its embryo-testing technology.YahooWhat's up with those weird tech startup ads on the subway?Tech startup advertising on New York City subways has surged, with tech ads rising 50% year over year in Q1 after a 30% increase in ad spending in 2024, now comprising 15% of all transit ads. Prices range from $5k to $60k per four weeks, with full-train wraps at $50k-$300k+, and AI startup Friend spent over $1m. Critics call the jargon-heavy B2B ads alienating, while others like Nucleus Genomics welcome the engagement.LarepublicaEl negocio genético de Silicon Valley que está prometiendo a bebes más inteligentesSilicon Valley startups including Nucleus, Orchid, and Herasight are offering preimplantation genetic testing for polygenic traits (PGT-P) that allow prospective parents to select embryos based on estimated characteristics such as intelligence, height, and disease risk. While the market is currently niche due to reliance on in vitro fertilization, venture capital investment in fertility companies has nearly doubled since 2019, reflecting significant commercial interest despite scientific limitations regarding prediction accuracy.Nate'Choose a perfect baby for 70 million won'... 'Stir' in subway advertisements: Nate NewsEmbryo selection startups, including HeraSight and Nucleus Genomics, are launching genetic testing services that allow prospective parents to predict traits such as intelligence, height, and disease risk. This commercial expansion is driven by significant venture capital investment in the U.S. infertility sector, with investments nearly doubling between 2019 and 2022 despite intense ethical controversy regarding eugenics and regulation.The EconomistHow much would you pay for a smarter baby?Startups, including Nucleus, promote embryo screening services in major US cities, claiming they can test for genetic diseases and IQ, which has generated controversy and public debate.TrendHunter.comGenetic Insight IVF PartnershipsNucleus Genomics has established an IVF+ partnership with the Fertility Institute of Hawaii, Hawaii's largest in vitro fertilization practice, to provide advanced carrier screening and embryo analysis to patients. The company's Preview and Embryo services screen for more than 2,000 genetic conditions and traits, with reported effectiveness rates including a 67% decrease for type 1 diabetes and 55% for Alzheimer's disease. The growing demand, evidenced by a waitlist of over 3,000 patients and expansion across multiple states and countries, signals a broader shift toward precision medicine in reproductive care.dev.uaGene-edited humans are on the way: scientists are concerned about a new experiment with embryosA Columbia University team edited two genomic sites in human zygotes using base editing, a more precise alternative to CRISPR. The study, not yet peer-reviewed, showed mixed results with significant mosaicism, raising concerns about potential medical problems. Critics warn it could pave the way for embryo editing for enhancement.GlobeNewswireFertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to ExpandNucleus Genomics announced a partnership with the Fertility Institute of Hawaii to provide advanced genetic embryo analysis during IVF, expanding access for both local and international patients. The collaboration enables deeper genetic risk insights and offers genomic-based embryo selection to reduce risks of conditions such as cancer, diabetes, and heart disease. Nucleus continues its rapid expansion across various regions with a growing waitlist of patients.